PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

90 hedge funds and large institutions have $156M invested in Pacific Biosciences in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-12
Holders Change %
-11.76%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
8
Increased
35
Reduced
31
Closed
20
Calls
$276K
Puts
$169K
Net Calls
+$107K
Net Calls Change
+$213K

Top Buyers

1
RCM
1
Raging Capital Management
New Jersey
$5.73M
2
CCM
2
Consonance Capital Management
New York
$22.9M
3
DM
3
Deerfield Management
New York
$8M
4
MC
4
Maverick Capital
Texas
$27.3M
5
BIT
5
BlackRock Institutional Trust
California
$5.15M

Top Sellers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$0
2
BA
2
BlackRock Advisors
Delaware
$5.71M
3
Millennium Management
3
Millennium Management
New York
$10.6M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$0
5
IHM
5
Iguana Healthcare Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Verition Fund Management
101
Verition Fund Management
Connecticut
– -$96K -16,585 Closed
VAM
102
Visium Asset Management
New York
– -$59K -10,300 Closed
AWP
103
Ascent Wealth Partners
New York
– -$58K -10,000 Closed
Simplex Trading
104
Simplex Trading
Illinois
– -$7K -1,275 Closed
Invesco
105
Invesco
Georgia
– -$6K -1,052 Closed
Canada Life
106
Canada Life
Manitoba, Canada
– -$5K -1,000 Closed
TDC
107
Thompson Davis & Co
Virginia
– -$3K -500 Closed
QT
108
Quantbot Technologies
New York
– -$1K -260 Closed
MFS
109
MSI Financial Services
Massachusetts
– -$1K -250 Closed
1 2 3 4
5